Graham K. Cooper's most recent trade in Beam Therapeutics Inc was a trade of 19,676 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 3, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2026 | 19,676 | 19,676 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2025 | 33,662 | 33,662 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 23,114 | 23,114 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 26,000 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 26,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 0 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 8,896 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 0 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2023 | 8,896 | 8,896 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 16,532 | 16,532 | - | - | Stock Option (Right to Buy) | |
| Beam Therapeutics Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 10,391 | 10,391 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
| Kezar Life Sciences Inc | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 26,000 | 26,000 | - | - | Stock Option (right to buy) | |
| Applied Molecular Transpor... | Graham K. Cooper | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) |